Table 2.
Initial diagnosis of HA20 | Total (n = 89) | OTU+ZnF (n = 50) | OTU (n = 13) | ZnF (n = 26) | Fisher | P-value |
---|---|---|---|---|---|---|
BD | 43% (38/89) | 48% (24/50) | 77% (10/13) | 15% (4/26) | 15.044 | 0.001 |
0.116a | ||||||
0.006b | ||||||
<0.001c | ||||||
iBD | 26% (23/89) | 28% (14/50) | 46% (6/13) | 12% (3/26) | 5.654 | 0.068 |
JIA | 12% (11/89) | 16% (8/50) | 0% (0/13) | 12% (3/26) | 2.052 | 0.362 |
PFAPA | 7% (6/89) | 4% (2/50) | 0% (0/13) | 15% (4/26) | 3.526 | 0.172 |
CD | 6% (5/89) | 4% (2/50) | 0% (0/13) | 12% (3/26) | 2.087 | 0.418 |
RA | 4% (4/89) | 6% (3/50) | 0% (0/13) | 4% (1/26) | 0.508 | 1.000 |
SLE | 4% (4/89) | 6% (3/50) | 0% (0/13) | 4% (1/26) | 0.508 | 1.000 |
PsA | 2% (2/89) | 2% (1/50) | 0% (0/13) | 4% (1/26) | 0.920 | 1.000 |
Comparison of the initial diagnosis between OTU+ZnF and OTU groups;
Comparison of the initial diagnosis between OTU+ZnF and ZnF groups;
Comparison of the initial diagnosis between OTU and ZnF groups. BD, Behcet's disease; iBD, intestinal Behcet's disease; JIA, juvenile idiopathic arthritis; PFAPA, periodic fever with aphthous pharyngitis and adenitis; CD, Crohn's disease; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; PsA, psoriatic arthritis.